Representative Matters

In his practice, Mr. Dougall has:

  • Represented a multinational and publicly traded pharmaceutical and medical device manufacturer in various health care fraud and antitrust investigations by the United States Department of Justice and by State Attorneys General.
  • Represented a very senior and global supervising managing director of an international investment bank in an accounting fraud investigation by the United States Department of Justice and the Securities and Exchange Commission.
  • Represented a hedge fund in a corruption investigation by a State Attorney General.
  • Represented the national brand manager of a multinational and publicly traded pharmaceutical and medical device manufacturer in an off-label marketing and health care fraud investigation by the United States Department of Justice.
  • Represented a very senior and supervising managing director of an international investment bank in a securities fraud investigation by a State Attorney General.
  • Represented an international investment bank in connection with conducting diligence concerning a health care industry issuer.
  • Represented a multinational and publicly traded pharmaceutical and medical device manufacturer in a health care fraud investigation by the United States Department of Justice.
  • Represented a U.S. regional sales director of a multinational and publicly traded pharmaceutical and medical device manufacturer in an off-label marketing and health care fraud investigation by the United States Department of Justice.
  • Represented an international security consultant in an investigation under the Foreign Corrupt Practice Act by the United States Department of Justice.
  • Represented a corporation that provided management services to health care providers in False Claims Act litigation brought by the United States Department of Justice and the New York State Attorney General.
  • Represented a corporate director and officer of a publicly traded petroleum company in a stock manipulation investigation by the United States Department of Justice and the Securities and Exchange Commission.

top of page